About AbbVie
AbbVies mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peoples lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womens health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
Key responsibilities:
* Develop recovery and purification process that utilizes clarification, chromatography, and membrane filtration technologies for recombinant proteins
* Design and execute innovative process development and characterization activities, impurity and viral clearance studies
* Is responsible for technology transfer to scale-up labs and manufacturing facilities, troubleshooting and investigation activities
* Act as lead purification scientist in a project CMC team and collaborate with cross-functional team members to drive the project progress toward milestones
* Address and solve technical problems independently, conceive and implement innovative process research ideas, evaluate and integrate state-of-the-art technology to improve manufacturing platform, pursue deep understanding of the process and product, and demonstrate a high level of scientific initiative
* Author technical report, support and contribute to regulatory filings
* Provide project update and analysis to cross-functional team and management
* Present original work internally across departments and at internal and external conferences
* May author or co-author peer-reviewed scientific papers or patents
Qualifications
Qualifications:
* BS, MS, or PhD degree in chemical engineering or biochemical engineering or related disciplines
* 10-12+ (BS), 8-10+ (MS), or 0-3+ (PhD) years of experiences in protein purification process development and/or manufacturing support
* Sound scientific understanding of protein separation technologies and ability to explore and develop new approaches to further advance innovative purification technologies desirable
* Experiences in protein chromatography, membrane filtration, mechanistic and process modeling, a plus
* Basic knowledge in related functional areas, such as cell culture, protein chemistry and analytics or formulation, a plus
* Demonstrated record of independent thinking, creativity and scientific accomplishment (e.g. peer reviewed journal publications, patents)
* Candidate must be a goal oriented team player with excellent verbal and written communication skills
Key Leadership Competencies:
* Builds strong relationships with peers and cross functionally with partners outside of team to enable higher performance
* Learns fast, grasps the essence and can change course quickly where indicated
* Raises the bar and is never satisfied with the status quo
* Creates a learning environment, open to suggestions and experimentation for improvement
* Embraces the ideas of others, nurtures innovation and manages innovation to reality
Significant Work Activities
Continuous standing for prolonged periods (more than 2 consecutive hours in an 8 hour day)
Travel
No
Job Type
Experienced
Schedule
Full-time
Job Level Code
IC
Equal Employment Opportunity
At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.
Chicago, IL
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia.
Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.